Northwestern Mutual Wealth Management CO Crispr Therapeutics Ag Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 4,670 shares of CRSP stock, worth $206,554. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,670
Previous 4,606
1.39%
Holding current value
$206,554
Previous $248,000
11.69%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CRSP
# of Institutions
487Shares Held
57.9MCall Options Held
1.09MPut Options Held
1.9M-
Capital International Investors Los Angeles, CA7.93MShares$351 Million0.07% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.5MShares$332 Million3.35% of portfolio
-
State Street Corp Boston, MA2.99MShares$132 Million0.01% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.97MShares$131 Million0.1% of portfolio
-
Nikko Asset Management Americas, Inc.2.97MShares$131 Million1.61% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.45B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....